Product Details

Opdyta 40mg Injection contains Nivolumab, an immune checkpoint inhibitor that targets the programmed death-1 (PD-1) pathway, a mechanism used by cancer cells to avoid being attacked by the immune system. By inhibiting PD-1, Nivolumab reactivates T-cells to recognize and destroy cancer cells. This immunotherapy is used to treat several types of advanced cancers, often in cases where other treatments have failed or are unsuitable.